Centrosomal protein TRIM43 restricts herpesvirus infection by regulating nuclear lamina integrity.


Journal

Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869

Informations de publication

Date de publication:
01 2019
Historique:
received: 06 01 2018
accepted: 08 10 2018
pubmed: 14 11 2018
medline: 18 6 2019
entrez: 14 11 2018
Statut: ppublish

Résumé

Tripartite motif (TRIM) proteins mediate antiviral host defences by either directly targeting viral components or modulating innate immune responses. Here we identify a mechanism of antiviral restriction in which a TRIM E3 ligase controls viral replication by regulating the structure of host cell centrosomes and thereby nuclear lamina integrity. Through RNAi screening we identified several TRIM proteins, including TRIM43, that control the reactivation of Kaposi's sarcoma-associated herpesvirus. TRIM43 was distinguished by its ability to restrict a broad range of herpesviruses and its profound upregulation during herpesvirus infection as part of a germline-specific transcriptional program mediated by the transcription factor DUX4. TRIM43 ubiquitinates the centrosomal protein pericentrin, thereby targeting it for proteasomal degradation, which subsequently leads to alterations of the nuclear lamina that repress active viral chromatin states. Our study identifies a role of the TRIM43-pericentrin-lamin axis in intrinsic immunity, which may be targeted for therapeutic intervention against herpesviral infections.

Identifiants

pubmed: 30420784
doi: 10.1038/s41564-018-0285-5
pii: 10.1038/s41564-018-0285-5
pmc: PMC6294671
mid: NIHMS992321
doi:

Substances chimiques

Antigens 0
DUX4L1 protein, human 0
Homeodomain Proteins 0
RNA, Small Interfering 0
TRIM43 protein, human 0
Tripartite Motif Proteins 0
pericentrin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-176

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI087846
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI127774
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI118509
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007183
Pays : United States

Références

Nat Rev Mol Cell Biol. 2005 Jan;6(1):21-31
pubmed: 15688064
J Virol. 2013 Jun;87(12):7102-12
pubmed: 23596303
Hum Mol Genet. 2014 Jan 1;23(1):171-81
pubmed: 23966205
J Immunol. 2005 Jun 1;174(11):6829-38
pubmed: 15905524
Dev Cell. 2012 Jan 17;22(1):38-51
pubmed: 22209328
Gene Expr Patterns. 2009 Dec;9(8):595-602
pubmed: 19703589
J Clin Invest. 2016 Sep 1;126(9):3165-75
pubmed: 27584730
Nat Cell Biol. 2011 Jul 10;13(8):966-72
pubmed: 21743463
Nat Rev Cancer. 2010 Dec;10(12):878-89
pubmed: 21102637
PLoS Pathog. 2014 Jan;10(1):e1003863
pubmed: 24453968
Cell. 1994 Feb 25;76(4):639-50
pubmed: 8124707
PLoS One. 2014 Jan 22;9(1):e87016
pubmed: 24466316
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4997-5002
pubmed: 21383178
J Clin Invest. 2016 Nov 1;126(11):4187-4204
pubmed: 27721236
Brief Bioinform. 2013 Nov;14(6):671-83
pubmed: 22988256
Nature. 2007 Apr 19;446(7138):916-920
pubmed: 17392790
Virology. 2004 Aug 1;325(2):225-40
pubmed: 15246263
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9593-8
pubmed: 22647604
J Virol. 2011 Aug;85(16):8116-32
pubmed: 21680520
Nat Rev Immunol. 2012 Oct;12(10):687-95
pubmed: 22976433
Hum Mol Genet. 2009 Jul 1;18(13):2414-30
pubmed: 19359275
Nucleic Acids Res. 2016 Jul 8;44(W1):W3-W10
pubmed: 27137889
Curr Opin Genet Dev. 2015 Aug;33:56-61
pubmed: 26356006
Science. 2010 Sep 24;329(5999):1650-3
pubmed: 20724583
PLoS Pathog. 2008 May 23;4(5):e1000071
pubmed: 18497856
J Cell Sci. 2009 Mar 1;122(Pt 5):577-86
pubmed: 19225124
Nat Rev Mol Cell Biol. 2007 Dec;8(12):1006-16
pubmed: 17928811
J Virol Methods. 1989 Feb;23(2):157-67
pubmed: 2542350
Nat Immunol. 2016 May;17(5):523-30
pubmed: 26998762
J Cell Biol. 1998 Apr 6;141(1):163-74
pubmed: 9531556
Nat Genet. 2017 Jun;49(6):941-945
pubmed: 28459456
Sci Signal. 2014 Jan 07;7(307):ra3
pubmed: 24399297
Nat Biotechnol. 2016 May;34(5):528-30
pubmed: 27088723
Nat Commun. 2015 Dec 09;6:10076
pubmed: 26647647
J Virol. 2006 Jun;80(11):5423-34
pubmed: 16699023
PLoS One. 2009;4(3):e4894
pubmed: 19290053
Nat Genet. 2017 Jun;49(6):935-940
pubmed: 28459454
Nat Genet. 2017 Jun;49(6):925-934
pubmed: 28459457
J Virol. 2016 Jun 10;90(13):5850-5854
pubmed: 27053550
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
J Virol. 1968 Oct;2(10):955-61
pubmed: 4302013
J Mol Biol. 2014 Mar 20;426(6):1265-84
pubmed: 24333484
Nat Rev Immunol. 2008 Nov;8(11):849-60
pubmed: 18836477
N Engl J Med. 2009 Oct 1;361(14):1376-85
pubmed: 19797284
Cell. 2013 Mar 14;152(6):1376-89
pubmed: 23498944

Auteurs

Florian Full (F)

Department of Microbiology, The University of Chicago, Chicago, IL, USA.
Institute for Clinical and Molecular Virology, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.

Michiel van Gent (M)

Department of Microbiology, The University of Chicago, Chicago, IL, USA.

Konstantin M J Sparrer (KMJ)

Department of Microbiology, The University of Chicago, Chicago, IL, USA.
Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Cindy Chiang (C)

Department of Microbiology, The University of Chicago, Chicago, IL, USA.

Matthew A Zurenski (MA)

Department of Microbiology, The University of Chicago, Chicago, IL, USA.

Myriam Scherer (M)

Institute of Virology, Ulm University Medical Center, Ulm, Germany.

Norbert H Brockmeyer (NH)

Department of Dermatology, Venerology, and Allergology, Center for Sexual Health and Medicine, Ruhr University Bochum, Bochum, Germany.

Lucie Heinzerling (L)

Department of Dermatology, University Hospital Erlangen, Erlangen, Germany.

Michael Stürzl (M)

Division of Molecular and Experimental Surgery, Department of Surgery, University Hospital Erlangen, Erlangen, Germany.

Klaus Korn (K)

Institute for Clinical and Molecular Virology, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.

Thomas Stamminger (T)

Institute of Virology, Ulm University Medical Center, Ulm, Germany.

Armin Ensser (A)

Institute for Clinical and Molecular Virology, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.

Michaela U Gack (MU)

Department of Microbiology, The University of Chicago, Chicago, IL, USA. mgack@uchicago.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH